Search research articles
Contact Us
Filters
Showing results (171-180 of 210) with videos related to
Page
of 21
Sort By:
Inflammatory Bowel Diseases
|
January 13, 2017
Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis
Kay Diederen, Lissy de Ridder, Patrick van Rheenen, et al.
JCI Insight
|
February 27, 2025
Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4
Marcel Arias-Badia, PeiXi Chen, Yee May Lwin, et al.
Endocrine
|
January 21, 2021
Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series
Medard F M van den Broek, Ester B G Rijks, Peter G J Nikkels, et al.
Cell Reports
|
July 21, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Cell Reports
|
May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Neurology
|
February 24, 2001
Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease
R Kumar, A E Lang, M C Rodriguez-Oroz, et al.
Inflammatory Bowel Diseases
|
May 3, 2012
IL-10R polymorphisms are associated with very-early-onset ulcerative colitis
Christopher J Moran, Thomas D Walters, Cong-Hui Guo, et al.
European Journal of Pediatrics
|
June 7, 2022
Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease
Maria M E Jongsma, Stephanie A Vuijk, Martinus A Cozijnsen, et al.
The Journal of Clinical Investigation
|
December 1, 2025
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site
Ty A Sornberger, Rachael M Wolters, Iuliia M Gilchuk, et al.
Clinical Pharmacokinetics
|
October 29, 2025
Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration
Q Zhao, M M E Jongsma, S A Vuijk, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 210) with videos related to
Sort By:
Page
of 21
Inflammatory Bowel Diseases
|
January 13, 2017
Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis
Kay Diederen, Lissy de Ridder, Patrick van Rheenen, et al.
JCI Insight
|
February 27, 2025
Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4
Marcel Arias-Badia, PeiXi Chen, Yee May Lwin, et al.
Endocrine
|
January 21, 2021
Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series
Medard F M van den Broek, Ester B G Rijks, Peter G J Nikkels, et al.
Cell Reports
|
July 21, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Cell Reports
|
May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Neurology
|
February 24, 2001
Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease
R Kumar, A E Lang, M C Rodriguez-Oroz, et al.
Inflammatory Bowel Diseases
|
May 3, 2012
IL-10R polymorphisms are associated with very-early-onset ulcerative colitis
Christopher J Moran, Thomas D Walters, Cong-Hui Guo, et al.
European Journal of Pediatrics
|
June 7, 2022
Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease
Maria M E Jongsma, Stephanie A Vuijk, Martinus A Cozijnsen, et al.
The Journal of Clinical Investigation
|
December 1, 2025
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site
Ty A Sornberger, Rachael M Wolters, Iuliia M Gilchuk, et al.
Clinical Pharmacokinetics
|
October 29, 2025
Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration
Q Zhao, M M E Jongsma, S A Vuijk, et al.
Page
of 21